Omega Healthcare Investors (OHI) Stock Forecast, Price Target & Predictions
OHI Stock Forecast
Omega Healthcare Investors stock forecast is as follows: an average price target of $35.73 (represents a -12.04% downside from OHI’s last price of $40.62) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.
OHI Price Target
The average price target for Omega Healthcare Investors (OHI) is $35.73 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $42.00 to $29.00. This represents a potential -12.04% downside from OHI's last price of $40.62.
OHI Analyst Ratings
According to 7 Wall Street analysts, Omega Healthcare Investors's rating consensus is 'Buy'. The analyst rating breakdown for OHI stock is 0 'Strong Buy' (0.00%), 4 'Buy' (57.14%), 3 'Hold' (42.86%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Omega Healthcare Investors Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 03, 2024 | Michael Lewis | Truist Financial | $39.00 | $39.66 | -1.67% | -3.99% |
| Aug 23, 2024 | James Feldman | Wells Fargo | $40.00 | $38.74 | 3.24% | -1.53% |
| Aug 23, 2024 | Michael Griffin | Griffin | $42.00 | $38.39 | 9.40% | 3.40% |
| Jun 25, 2024 | Michael Lewis | Truist Financial | $33.00 | $33.25 | -0.75% | -18.76% |
| Jun 21, 2024 | David Rodgers | Robert W. Baird | $32.00 | $33.00 | -3.03% | -21.22% |
| May 09, 2024 | Michael Carroll | RBC Capital | $32.00 | $30.83 | 3.80% | -21.22% |
| Apr 01, 2024 | Michael Lewis | Truist Financial | $32.00 | $31.82 | 0.57% | -21.22% |
| Feb 08, 2024 | Nate Crossett | BNP Paribas | $30.00 | $29.91 | 0.30% | -26.14% |
| Sep 08, 2023 | Vikram Malhotra | Mizuho Securities | $35.00 | $32.17 | 8.78% | -13.84% |
| Apr 26, 2022 | - | Barclays | $29.00 | $27.76 | 4.47% | -28.61% |
The latest Omega Healthcare Investors stock forecast, released on Sep 03, 2024 by Michael Lewis from Truist Financial, set a price target of $39.00, which represents a -1.67% decrease from the stock price at the time of the forecast ($39.66), and a -3.99% decrease from OHI last price ($40.62).
Omega Healthcare Investors Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 3 | 5 | 8 |
| Avg Price Target | $40.33 | $37.20 | $35.00 |
| Last Closing Price | $40.62 | $40.62 | $40.62 |
| Upside/Downside | -0.71% | -8.42% | -13.84% |
In the current month, the average price target of Omega Healthcare Investors stock is $40.33, according to 3 Wall Street analysts offering twelve months forecast. The average price target represents a -0.71% decrease as opposed to Omega Healthcare Investors's last price of $40.62. This month's average price target is up 8.41% compared to last quarter, and up 15.23% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 26, 2024 | Scotiabank | Sector Perform | Sector Perform | Hold |
| Aug 23, 2024 | Wells Fargo | Overweight | Overweight | Hold |
| Aug 23, 2024 | Citigroup | Buy | Buy | Hold |
| Jul 09, 2024 | Scotiabank | Sector Perform | Sector Perform | Hold |
| May 09, 2024 | RBC Capital | Sector Perform | Sector Perform | Hold |
| Mar 21, 2024 | Citigroup | Hold | Buy | Upgrade |
| Feb 26, 2024 | Wells Fargo | - | Overweight | Upgrade |
| Feb 08, 2024 | Exane BNP Paribas | - | Neutral | Upgrade |
| Dec 26, 2023 | Citigroup | Hold | Hold | Hold |
| Sep 12, 2023 | RBC Capital | - | Sector Perform | Initialise |
Omega Healthcare Investors's last stock rating was published by Scotiabank on Aug 26, 2024. The company gave OHI a "Sector Perform" rating, the same as its previous rate.
Omega Healthcare Investors Financial Forecast
Omega Healthcare Investors Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $239.32M | $242.03M | $250.19M | $218.20M | $144.85M | $239.43M | - | $249.31M | $249.95M | $281.67M | $257.42M | $273.77M | $263.79M | $119.18M | $256.39M | $253.02M | $246.67M | $233.19M |
| Avg Forecast | $250.80M | $247.00M | $243.90M | $241.00M | $236.10M | $233.17M | $230.88M | $227.42M | $219.47M | $215.78M | $205.92M | $200.59M | $205.32M | $210.65M | $198.84M | $175.52M | $209.93M | $213.98M | $216.73M | $208.83M | $235.23M | $231.76M | $229.66M | $226.09M | $216.83M | $183.42M | $225.53M | $216.05M | $203.97M | $194.77M |
| High Forecast | $270.10M | $266.01M | $262.67M | $259.54M | $254.26M | $251.12M | $248.65M | $244.92M | $236.36M | $222.78M | $221.77M | $216.03M | $210.38M | $219.11M | $214.15M | $189.03M | $226.08M | $230.44M | $216.73M | $219.87M | $247.66M | $244.01M | $241.81M | $238.05M | $228.30M | $193.12M | $237.45M | $227.48M | $214.76M | $205.07M |
| Low Forecast | $212.51M | $209.29M | $206.67M | $204.21M | $200.05M | $197.58M | $195.64M | $192.70M | $185.97M | $207.93M | $174.49M | $169.97M | $201.61M | $206.21M | $168.49M | $148.73M | $177.88M | $181.31M | $216.73M | $184.80M | $208.15M | $205.09M | $203.23M | $200.07M | $191.88M | $162.31M | $199.57M | $191.19M | $180.50M | $172.35M |
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 3 | 6 | 5 | 4 | 4 | 3 | 3 | 1 | 1 | 2 | 2 | 2 | 10 | 10 | 10 | 10 | 10 | 9 | 9 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.17% | 1.15% | 1.26% | 1.24% | 0.69% | 1.12% | - | 1.19% | 1.06% | 1.22% | 1.12% | 1.21% | 1.22% | 0.65% | 1.14% | 1.17% | 1.21% | 1.20% |
Omega Healthcare Investors's average Quarter revenue forecast for Mar 24 based on 3 analysts is $200.59M, with a low forecast of $169.97M, and a high forecast of $216.03M. OHI's average Quarter revenue forecast represents a -16.18% decrease compared to the company's last Quarter revenue of $239.32M (Dec 23).
Omega Healthcare Investors EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 3 | 6 | 5 | 4 | 4 | 3 | 3 | 1 | 1 | 2 | 2 | 2 | 10 | 10 | 10 | 10 | 10 | 9 | 9 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $193.22M | $233.10M | $212.17M | $200.46M | $63.59M | $212.73M | - | $227.07M | $177.75M | $285.00M | $230.14M | $304.31M | $203.42M | $45.78M | $239.00M | $229.50M | $196.53M | $268.10M |
| Avg Forecast | $218.10M | $214.79M | $212.10M | $209.58M | $205.31M | $202.77M | $200.78M | $197.76M | $190.86M | $187.64M | $179.07M | $174.44M | $178.54M | $183.18M | $172.92M | $152.64M | $182.55M | $186.08M | $188.47M | $171.05M | $204.55M | $201.54M | $215.76M | $156.21M | $188.56M | $125.79M | $214.49M | $187.88M | $177.38M | $125.34M |
| High Forecast | $234.88M | $231.32M | $228.42M | $225.70M | $221.11M | $218.37M | $216.23M | $212.98M | $205.54M | $193.73M | $192.85M | $187.86M | $182.95M | $190.54M | $186.22M | $164.38M | $196.60M | $200.40M | $188.47M | $205.26M | $215.37M | $212.20M | $258.91M | $187.45M | $198.53M | $150.94M | $257.39M | $197.82M | $186.75M | $150.40M |
| Low Forecast | $184.80M | $182.00M | $179.72M | $177.58M | $173.97M | $171.82M | $170.13M | $167.57M | $161.72M | $180.82M | $151.73M | $147.81M | $175.33M | $179.32M | $146.52M | $129.33M | $154.68M | $157.67M | $188.47M | $136.84M | $181.01M | $178.34M | $172.60M | $124.97M | $166.86M | $100.63M | $171.59M | $166.26M | $156.96M | $100.27M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | 1.27% | 1.23% | 1.31% | 0.35% | 1.14% | - | 1.33% | 0.87% | 1.41% | 1.07% | 1.95% | 1.08% | 0.36% | 1.11% | 1.22% | 1.11% | 2.14% |
3 analysts predict OHI's average Quarter EBITDA for Mar 24 to be $174.44M, with a high of $187.86M and a low of $147.81M. This is -9.72% lower than Omega Healthcare Investors's previous annual EBITDA (Dec 23) of $193.22M.
Omega Healthcare Investors Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 3 | 6 | 5 | 4 | 4 | 3 | 3 | 1 | 1 | 2 | 2 | 2 | 10 | 10 | 10 | 10 | 10 | 9 | 9 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $65.98M | $98.77M | $59.86M | $35.94M | $45.58M | $102.27M | - | $189.61M | $32.74M | $138.95M | $84.52M | $159.98M | $61.40M | $-91.29M | $99.31M | $89.92M | $59.54M | $138.74M |
| Avg Forecast | $107.23M | $104.61M | $104.61M | $104.61M | $103.74M | $101.13M | $100.25M | $99.38M | $99.91M | $99.91M | $92.93M | $118.30M | $91.42M | $87.05M | $80.64M | $107.54M | $144.37M | $143.29M | $98.86M | $97.77M | $51.00M | $130.26M | $79.24M | $82.12M | $82.36M | $-250.81M | $89.12M | $96.34M | $75.63M | $64.86M |
| High Forecast | $117.95M | $115.08M | $115.08M | $115.08M | $114.12M | $111.24M | $110.28M | $109.32M | $109.90M | $102.72M | $102.23M | $141.96M | $96.87M | $94.97M | $88.70M | $129.05M | $158.81M | $171.95M | $98.86M | $117.32M | $61.20M | $156.32M | $95.09M | $98.55M | $98.83M | $-200.65M | $106.95M | $115.61M | $90.76M | $77.83M |
| Low Forecast | $85.95M | $83.85M | $83.85M | $83.85M | $83.15M | $81.06M | $80.36M | $79.66M | $80.08M | $97.09M | $74.49M | $94.64M | $88.69M | $84.42M | $64.64M | $86.03M | $115.72M | $114.63M | $98.86M | $78.21M | $40.80M | $104.21M | $63.39M | $65.70M | $65.89M | $-300.97M | $71.30M | $77.07M | $60.51M | $51.89M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.72% | 1.13% | 0.74% | 0.33% | 0.32% | 0.71% | - | 1.94% | 0.64% | 1.07% | 1.07% | 1.95% | 0.75% | 0.36% | 1.11% | 0.93% | 0.79% | 2.14% |
Omega Healthcare Investors's average Quarter net income forecast for Mar 24 is $118.30M, with a range of $94.64M to $141.96M. OHI's average Quarter net income forecast represents a 79.28% increase compared to the company's last Quarter net income of $65.98M (Dec 23).
Omega Healthcare Investors SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 3 | 6 | 5 | 4 | 4 | 3 | 3 | 1 | 1 | 2 | 2 | 2 | 10 | 10 | 10 | 10 | 10 | 9 | 9 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $9.27M | $11.03M | $21.66M | $20.16M | $15.63M | $17.88M | - | $16.02M | $17.90M | $15.37M | $15.20M | $16.15M | $15.19M | $14.81M | $13.97M | $15.92M | $14.10M | $13.76M |
| Avg Forecast | $17.51M | $17.25M | $17.03M | $16.83M | $16.48M | $16.28M | $16.12M | $15.88M | $15.32M | $15.07M | $14.38M | $10.22M | $14.33M | $14.71M | $13.88M | $9.29M | $14.66M | $15.85M | $15.13M | $8.45M | $27.43M | $14.41M | $14.25M | $8.29M | $20.37M | $40.69M | $12.54M | $17.06M | $17.91M | $6.43M |
| High Forecast | $18.86M | $18.57M | $18.34M | $18.12M | $17.75M | $17.53M | $17.36M | $17.10M | $16.50M | $15.55M | $15.48M | $12.27M | $14.69M | $15.30M | $14.95M | $11.15M | $15.78M | $19.02M | $15.13M | $10.14M | $32.91M | $17.29M | $17.10M | $9.95M | $24.44M | $48.83M | $15.04M | $20.47M | $21.49M | $7.72M |
| Low Forecast | $14.84M | $14.61M | $14.43M | $14.26M | $13.97M | $13.79M | $13.66M | $13.45M | $12.98M | $14.52M | $12.18M | $8.18M | $14.08M | $14.40M | $11.76M | $7.43M | $12.42M | $12.68M | $15.13M | $6.76M | $21.94M | $11.53M | $11.40M | $6.63M | $16.30M | $32.56M | $10.03M | $13.65M | $14.33M | $5.15M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.65% | 0.75% | 1.56% | 2.17% | 1.07% | 1.13% | - | 1.90% | 0.65% | 1.07% | 1.07% | 1.95% | 0.75% | 0.36% | 1.11% | 0.93% | 0.79% | 2.14% |
Omega Healthcare Investors's average Quarter SG&A projection for Mar 24 is $10.22M, based on 3 Wall Street analysts, with a range of $8.18M to $12.27M. The forecast indicates a 10.24% rise compared to OHI last annual SG&A of $9.27M (Dec 23).
Omega Healthcare Investors EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 3 | 6 | 5 | 4 | 4 | 3 | 3 | 1 | 1 | 2 | 2 | 2 | 10 | 10 | 10 | 10 | 10 | 9 | 9 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.27 | $0.37 | $0.25 | $0.15 | $0.19 | $0.44 | - | $0.79 | $0.14 | $0.58 | $0.36 | $0.69 | $0.27 | $-0.40 | $0.44 | $0.40 | $0.27 | $0.64 |
| Avg Forecast | $0.41 | $0.40 | $0.40 | $0.40 | $0.40 | $0.39 | $0.38 | $0.38 | $0.38 | $0.38 | $0.36 | $0.32 | $0.35 | $0.33 | $0.31 | $0.28 | $0.55 | $0.39 | $0.38 | $0.33 | $0.47 | $0.43 | $0.43 | $0.45 | $0.41 | $0.15 | $0.40 | $0.42 | $0.39 | $0.40 |
| High Forecast | $0.45 | $0.44 | $0.44 | $0.44 | $0.44 | $0.43 | $0.42 | $0.42 | $0.42 | $0.39 | $0.39 | $0.35 | $0.37 | $0.36 | $0.34 | $0.31 | $0.61 | $0.43 | $0.38 | $0.35 | $0.50 | $0.46 | $0.46 | $0.48 | $0.43 | $0.16 | $0.42 | $0.45 | $0.41 | $0.43 |
| Low Forecast | $0.33 | $0.32 | $0.32 | $0.32 | $0.32 | $0.31 | $0.31 | $0.30 | $0.31 | $0.37 | $0.28 | $0.26 | $0.34 | $0.32 | $0.25 | $0.23 | $0.44 | $0.31 | $0.38 | $0.28 | $0.40 | $0.37 | $0.36 | $0.38 | $0.35 | $0.13 | $0.34 | $0.35 | $0.33 | $0.34 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.77% | 1.11% | 0.81% | 0.53% | 0.34% | 1.13% | - | 2.39% | 0.30% | 1.35% | 0.84% | 1.54% | 0.66% | -2.61% | 1.11% | 0.96% | 0.70% | 1.59% |
According to 3 Wall Street analysts, Omega Healthcare Investors's projected average Quarter EPS for Mar 24 is $0.32, with a low estimate of $0.26 and a high estimate of $0.35. This represents a 18.10% increase compared to OHI previous annual EPS of $0.27 (Dec 23).
Omega Healthcare Investors Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| LTC | LTC Properties | $37.69 | $38.67 | 2.60% | Hold |
| HR | Healthcare Realty Trust | $18.78 | $19.00 | 1.17% | Buy |
| VTR | Ventas | $65.06 | $60.97 | -6.29% | Buy |
| SBRA | Sabra Health Care REIT | $18.59 | $17.29 | -6.99% | Hold |
| OHI | Omega Healthcare Investors | $40.62 | $35.73 | -12.04% | Buy |
| CTRE | CareTrust REIT | $31.08 | $25.50 | -17.95% | Buy |
| NHI | National Health Investors | $85.05 | $67.25 | -20.93% | Hold |
OHI Forecast FAQ
Is Omega Healthcare Investors a good buy?
Yes, according to 7 Wall Street analysts, Omega Healthcare Investors (OHI) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 57.14% of OHI's total ratings.
What is OHI's price target?
Omega Healthcare Investors (OHI) average price target is $35.73 with a range of $29 to $42, implying a -12.04% from its last price of $40.62. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Omega Healthcare Investors stock go up soon?
According to Wall Street analysts' prediction for OHI stock, the company can go down by -12.04% (from the last price of $40.62 to the average price target of $35.73), up by 3.40% based on the highest stock price target, and down by -28.61% based on the lowest stock price target.
Can Omega Healthcare Investors stock reach $60?
OHI's average twelve months analyst stock price target of $35.73 does not support the claim that Omega Healthcare Investors can reach $60 in the near future.
What is Omega Healthcare Investors's current price target trend?
3 Wall Street analysts forecast a $40.33 price target for Omega Healthcare Investors (OHI) this month, down -0.71% from its last price of $40.62. Compared to the last 3 and 12 months, the average price target decreased by -8.42% and decreased by -13.84%, respectively.
What are Omega Healthcare Investors's analysts' financial forecasts?
Omega Healthcare Investors's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $927.57M (high $998.94M, low $785.97M), average EBITDA is $806.62M (high $868.69M, low $683.49M), average net income is $404.51M (high $444.97M, low $324.23M), average SG&A $64.76M (high $69.74M, low $54.88M), and average EPS is $1.55 (high $1.7, low $1.24). OHI's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $982.7M (high $1.06B, low $832.68M), average EBITDA is $854.56M (high $920.32M, low $724.11M), average net income is $421.07M (high $463.19M, low $337.51M), average SG&A $68.61M (high $73.89M, low $58.14M), and average EPS is $1.61 (high $1.77, low $1.29).
Did the OHI's actual financial results beat the analysts' financial forecasts?
Based on Omega Healthcare Investors's last annual report (Dec 2023), the company's revenue was $949.74M, beating the average analysts forecast of $790.33M by 20.17%. Apple's EBITDA was $797.15M, beating the average prediction of $687.28M by 15.99%. The company's net income was $261.89M, missing the average estimation of $366.65M by -28.57%. Apple's SG&A was $44.57M, missing the average forecast of $52.22M by -14.64%. Lastly, the company's EPS was $1.07, missing the average prediction of $1.27 by -15.93%. In terms of the last quarterly report (Dec 2023), Omega Healthcare Investors's revenue was $239.32M, beating the average analysts' forecast of $205.32M by 16.56%. The company's EBITDA was $193.22M, beating the average prediction of $178.54M by 8.22%. Omega Healthcare Investors's net income was $65.98M, missing the average estimation of $91.42M by -27.82%. The company's SG&A was $9.27M, missing the average forecast of $14.33M by -35.31%. Lastly, the company's EPS was $0.27, missing the average prediction of $0.35 by -22.76%